Passiflora Plex Liquid
NDC Package 62106-1322-0
Package Information
Passiflora Plex (passiflora incarnata, ignatia amara, jalapa, coffea cruda, magnesium metalicum, palladium metallicum, tellurium metallicum, phosphoricum acidum) liquids is usesFor the temporary relief of symptoms associated withirregular sleep patterns ordinary restlessness Directions To be taken ten minutes away from food. This formulation utilizes a liquid delivery system. Marketed by Seroyal Usa, this product is identified by NDC 62106-1322.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 62106 - Seroyal Usa
- 62106-1322 - Passiflora Plex
- 62106-1322-0 - 1 BOTTLE, GLASS in 1 BOX / 30 mL in 1 BOTTLE, GLASS
- 62106-1322 - Passiflora Plex
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62106-1322-0 identifies a specific commercial package of 1 bottle, glass in 1 box / 30 ml in 1 bottle, glass of Passiflora Plex, a human over the counter drug labeled by Seroyal Usa. This liquid is formulated for sublingual use and contains arabica coffee bean; ipomoea purga root; magnesium; palladium; passiflora incarnata flowering top; phosphoric acid; strychnos ignatii seed; tellurium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Seroyal Usa on February 09, 2015. The current certification is valid through December 31, 2026.
How is this Seroyal Usa product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62106132200. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.